FN1 and breast cancer: Between the two different breast cancer lines used in this work, the endogenous EDB-FN level in the least aggressive HR+ MCF7 cells is significantly lower than that in the more aggressive HR− MDA-MB-468 cells, despite both lines exhibiting an epithelial phenotype.